No Content

No Content

No Content

No Content

No Content

No Content

No Content

No Content

No Content

No Content

No Content

No Content

No Content

No Content

No Content

No Content

No Content

No Content

No Content

No Content

We are excited to welcome two new data partners in the HONEUR network: IRST Meldola The Romagnolo Institute for the Study of Tumors "Dino Amadori" - IRST is a center of excellence entirely...

We are pleased to announce the addition of OncologyInformationService to our network! O.I.s) is providing longitudinal real-world data in solid tumors and haematological malignancies in the EUCAN...

It is with great pleasure that we announce the addition of our 11th HONUR data partner: CHU Montpellier! CHU Montpellier is a French University hospital center focused on care, teaching and...

HONEUR Newsletter - Winter 2022 edition

In light of the success of our very first HONEUR Forum meeting on 23 September 2022, we are happy to announce the date of the second HONEUR Forum meeting: 25-26 MAY 2023! We are inviting all our...

A warm welcome to our 21st HONEUR Data Partner: Cardiff and Vale! Cardiff and Vale University Health Board includes the University Hospital of Wales and has strong links to Cardiff University. UHW...

We held a voting session during our HONEUR Forum meeting on 23 September, and are delighted to inform you all that our HONEUR Working Charter has been officially released! Our Working Charter...

HONEUR has sent out its very first HONEUR Newsletter! In this edition: 19 HONEUR data partners 2022 News and milestones: current studies, publications, and new capabilities HONEUR governance model...

Have a look at our first publication: “The Value of Federated Data Networks in Oncology: What Research Questions Do They Answer? Outcomes From a Systematic Literature Review.” In this paper, we...

We are proud to inform you about our latest publication: “Haematology Outcomes Network in Europe (HONEUR)—A collaborative, interdisciplinary platform to harness the potential of real-world data in...

We are delighted to share that four data partners have joined the network, from four different countries! Tel Aviv Sourasky Medical Center – Israel Tel Aviv Sourasky Medical Center's division of...

We are proud to share with you that we currently have over 23.000 patients from 7 HONEUR sites mapped in the HONEUR network. Nearly 17.000 are in multiple myeloma. We also now have over 4.000 CLL...

ITEM CODE: RF-251515 | DATE OF PREPARATION: JANUARI 2023

ITEM CODE: RF-251517 | DATE OF PREPARATION: JANUARY 2023

This site is published by Janssen Pharmaceutica N.V., which is solely responsible for its content. This site is intended for the use of our visitors in Europe, the Middle East and Africa. Last...

ITEM CODE: RF-272618 | DATE OF PREPARATION: 28 JUNE 2023

We are delighted to inform you that our HONEUR Project Lead, Kristina Bardenheuer, was invited for an interview with The Evidence Base®, on HONEUR and Federated Data Networks. Kristina explained...

It is with great pride that we look back at our very first HONEUR Forum meeting, which was held on 23 September 2022. A special thanks to our external speakers and hybrid audience who contributed...

We would like to share a moment of pride and accomplishment as our HONEUR (Haematological Outcomes Network in Europe) analysis with title “Real-World Patient Characteristics and Survival Outcomes...

Exciting News! Our second hybrid HONEUR Forum, organized on 25-26 May 2023 in Amsterdam was a success!